SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-040235
Filing Date
2024-04-02
Accepted
2024-04-02 16:30:15
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4358
  Complete submission text file 0000950170-24-040235.txt   5880
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35 NAARDEN P7 1411 DC
Business Address
Audet Juliette Berangere (Reporting) CIK: 0002000393 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41562 | Film No.: 24814737